About |Personalized Medicine and Public Health

LONGDOM takes the privilege to invite all to join the "2^ndWorld Congress on Personalized Medicine" in Tokyo, Japan during Sep 01-02, 2021. It brings together leading Pathologists, Specialists, Clinical Geneticist, Cytogenetic Diagnostics, Therapists, Researchers Specialized from Molecular Genetics and Genomics, Physicians and Hospitalists with different specialties such as Endocrinologist, Cardiologist, Nephrologist, Orthopedics, Hematologist’s, Immunologists, Oncologists, Rheumatologist, Research scholars, Industrial professionals and Student delegates from Biomedical, Pharmaceuticals and Telemedicine and Healthcare professionals to exchange their views on critical aspects of Medicine research. Medicine 2020 includes worldwide attendee Workshops, lectures, and exhibitions, poster presentations.

Aim of Medicine 2021:

Personalized Medicine 2021 aims to provide an excellent opportunity to share views, exchange knowledge and establish research collaborations & networking.

Sessions:

Track 1: Personalized medicine

Personalized medicine, precision medicine, or theranostics is a medical model that separates people into different groups with medical decisions, practices, interventions and/or products being tailored to the individual patient based on their predicted response or risk of disease. The terms personalized medicine; precision medicine, stratified medicine and P4 medicine are used interchangeably to describe this concept through some authors and organizations use these expressions separately to indicate particular nuances. While the tailoring of treatment to patients dates back at least to the time of Hippocrates, the term has risen in usage in recent years given the growth of new diagnostic and informatics approaches that provide an understanding of the molecular basis of disease, particularly genomics. This provides a clear evidence base on which to stratify (group) related patients

Track 2: Personalized medicine: Drug discovery and patient care

Advances in human genome research are opening the door to a new paradigm for practicing medicine that promises to transform healthcare. Personalized medicine, the use of marker-assisted diagnosis and targeted therapies derived from an individual's molecular profile, will impact the way drugs are developed and medicine is practiced. Knowledge of the molecular basis of disease will lead to novel target identification, toxic genomic markers to screen compounds and improved selection of clinical trial patients, which will fundamentally change the pharmaceutical industry. The traditional linear process of drug discovery and development will be replaced by an integrated and heuristic approach. In addition, patient care will be revolutionized through the use of novel molecular predisposition, screening, diagnostic, prognostic, pharmacogenomics and monitoring markers. Although numerous challenges will need to be met to make personalized medicine a reality, with time, this approach will replace the traditional trial-and-error practice of medicine.

Track 3: Individualized Treatment through Personalized Medicine

This perspective addresses conceptual approaches that can be undertaken to develop and apply clinical decision support in electronic health record systems to achieve personalized medical care. In addition, to represent meaningful benefits to personalized decision-making, a comparison of current and future applications of clinical decision support to enable individualized medical treatment plans is presented. If clinical decision support tools are to impact outcomes in a clear and positive manner, their development and deployment must therefore consider the needs of the providers, including specific practice needs, information workflow, and practice environment.

Track 4: Personalized Medicine in Oncology

The development of cost-effective technologies able to comprehensively assess DNA, RNA, protein, and metabolites in patient tumours has fuelled efforts to tailor medical care. Indeed validated molecular tests assessing tumour tissue or patient germ line DNA already drive therapeutic decision making. However, many theoretical and regulatory challenges must still be overcome before fully realizing the promise of personalized molecular medicine. The masses of data generated by high-throughput technologies are challenging to manage, visualize, and convert to the knowledge required to improve patient outcomes. Systems biology integrates engineering, physics, and mathematical approaches with biologic and medical insights in an iterative process to visualize the interconnected events within a cell that determine how inputs from the environment and the network rewiring that occurs due to the genomic aberrations acquired by patient tumours determines cellular behaviour and patient outcomes. A cross-disciplinary systems biology effort will be necessary to convert the information contained in multidimensional data sets into useful biomarkers that can classify patient tumours by prognosis and response to therapeutic modalities and to identify the drivers of tumour behaviour that are optimal targets for therapy. An understanding of the effects of targeted therapeutics on signalling networks and homeostatic regulatory loops will be necessary to prevent inadvertent effects as well as to develop rational combinatorial.

Track 5: Preventive Medicine & Public Health Care

Preventive Medicine is sharpened by all specialists to keep their patients sound. It is also an extraordinary therapeutic distinguishing strength saw by the American Board of Medical Specialties (ABMS). Preventive Medicine focuses on the prosperity of individuals, gatherings, and portrayed peoples. It is similarly used for the treatment for strength, visual hindrance. The Epidemiology Division applies inquire about systems to illustrations and explanations behind prosperity and affliction in the people and to make a translation of this learning into ventures proposed to turn away disease. The division has a long history of consideration in NIH-bolstered multi-site, longitudinal accomplice studies, and its staff deal with various pro began, NIH-upheld investigation endeavours and trials. Open trust in antibodies is a key to the accomplishment of immunization ventures worldwide in the time of preventive solution. The focus of Preventive Medicine and Public Health is health of individuals, communities, and defined populations. To, maintain health and protect, promote and to prevent disease, death and disability. The result of Public health surveillance is the identification and prioritization of public health issues the world is facing today, including HIV/AIDS, antibiotic resistance, diabetes, zoonotic diseases, and waterborne diseases. Preventive Medicine and Public health incorporates the interdisciplinary approaches of epidemiology, biostatistics and health services.

Track 6: Precision Medicine: Oncology and Cardiovascular

Precision Medicine in Oncology is doled out to illuminating, instructing, and encouraging the trading of clinically pertinent data with respect to the disclosure and utilization of new Drug regimens, Molecular biomarkers, Cancer genomics, Molecular growth and Diagnostics in strong tumors and hematologic malignancies, and in addition their effect on oncology watch over patients. Over late decades Cancer investigate has found an incredible and personalized medication to tumor research and treatment. The goal of the Personalized Medicine in cardiac research is to stimulate understanding of promising new essential examination disclosures for the treatment of heart disillusionment and arrhythmias through especially formed clinical trials that display suitability and security. Vascular Medicine encompasses an extensive variety of various sickness states. As the field of vascular Medicine builds up, the degree of ailments being managed changes. Cardiovascular revamping suggests the changes in estimate, shape, structure and physiology of the heart after harm to the myocardium. The mischief is regularly a direct result of extraordinary myocardial dead tissue. To depict the development in lipoprotein translation by hypothyroidism, adipocytes were prepared from control and hypothyroid rats. While LPL mix was higher in hypothyroid adipocytes, with no modification in mRNA levels, there was no extension in hormone-delicate lipase (HSL) mix.

Market Analysis:

This Conference will provide a perfect platform to all the International mix of leading Research Scholars, and Scientists achieved eminence in their field of study, research academicians from the universities and research institutions, industrial research professionals and business associates along with PhD Students to come and inform all the attendees about the latest scientific advancements on the respective sphere. The global personalized medicine in the market was valued at USD 1,007.88 billion in 2018 and is expected to reach USD 2,452.50 billion in 2022, growing at a CAGR of 11.8% over the forecast period. Key drivers of the market include growing development of next-generation sequencing, whole genome technology, companion diagnostics and the growing number of retail clinics. Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, the growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth. Increasing adoption of next-generation sequencing for genetic mapping of patients by clinicians and medical practitioners worldwide and growing support for personalized medicine by reimbursement and regulatory landscape are also factors expected to drive demand through to 2022. Market growth is also expected to rise through the novel introduction of drugs with associated and companion diagnostics, and growing usage of highly sensitive, accurate genetic diagnostic techniques for disease testing and risk assessment. Anticipated increase advanced DNA diagnostic usage combined with the reduction in implementation costs for whole genome sequencing is expected to considerably increase penetration rates.

Past Conference Report

Euro Personalized Medicine 2020:

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Euro Personalized Medicine 2020 conference the best ever!

International conference Euro Personalized Medicine hosted by the Longdom Conference was held during May 19-20, 2020 Berlin, Germany based on the theme “Exploring Advances of COVID-19 in Personalized Medicine and Pharmacogenomics”

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Dr Sergio Marcucci, Luxembourg
Dr Rahul Hajare, India
Dr Amr Elnaggar, UAE
DR.ANIL BATTA , Govt.Medical College, India
Prof Magdy Abouzeid, Egypt

With the grand success of Euro Personalized Medicine 2020, Longdom Conferences is proud to announce the " Global Summit on Personalized Medicine and Health Care" to be held Sep 01-02, 2021 Tokyo, Japan

For More details visit: https://www.longdom.com/personalized-medicine

Webinar On Public Health 2020 :

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Webinar on public health and nutrition the best ever!

International Webinar on Public Health and Nutrition hosted by the Longdom Conference was held during September 18, 2020 at London, UK based on the theme “Lets make the world healthier and happier".

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Anson, C.Y. Tang, Tung Wah College, Hong Kong.
Wong Florence, Tung Wah College, Hong Kong.
Rina Karmila , Universitas Indonesia, Indonesia.
Elaine Chow, Tung Wah College, Hong Kong.
Tippawan Muknumporn, Khon Kaen University,Thailand

With the grand success of Webinar on public health 2020, Longdom Conferences is proud to announce the " Global Summit on Personalized Medicine and Health Care" to be held Sep 01-02, 2021 Tokyo, Japan

For More details visit: https://www.longdom.com/personalized-medicine

Euro public health 2020:

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making International Conference On Public Health & Healthcare the best ever!

International conference on Public health & healthcare , hosted by the Longdom Conference was held during September 17, 2020 at Paris, France based on the theme “General well being for tomorrows mankind “ The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Tippawan Muknumporn, Khon Kaen University, Thailand.
Yoshiko Yamaguchi, Kwassui Women’s University, Japan.
Catharine Jenkins, Birmingham City University, UK.
Luk Hi Kwan,Tung Wah College, Hong Kong.
Darcy Hostetter-Lewis, California State University,USA

With the grand success of Euro public health 2020, Longdom Conferences is proud to announce the " Global Summit on Personalized Medicine and Health Care" to be held Sep 01-02, 2021 Tokyo, Japan

For More details visit: https://www.longdom.com/personalized-medicine

Nursing Summit 2019:

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Nursing Summit 2019 Webinar the best ever!

East Asian Congress on Nursing and Primary Health Care, hosted by the Longdom Conference was held during May 13-14, 2019 at Tokyo, Japan based on the theme “The Power of Nursing and Primary Care Creating a Quality Experience for All"

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Dr David Boulton, National Association of School Superintendents, USA
Adrian Low, Vézina McGill University, Hong kong
Dr. Lea Lis, New York University Medical Center, USA
Olivia Levine, Sackler School of Medicine, USA
Helen Brice, University of Edinburgh, UK

With the grand success of Nursing Summit 2019, Longdom Conferences is proud to announce the " Global Summit on Personalized Medicine and Health Care" to be held Sep 01-02, 2021 Tokyo, Japan

For More details visit: https://www.longdom.com/personalized-medicine

Webinar On Nursing Skills And Techniques

We gratefully thank all our wonderful Speakers, webinar Attendees, Students, Media Partners, Associations and Exhibitors for making Webinar on nursing skills and techniques the best ever.

International Webinar on “Nursing skills and techniques” hosted by the Longdom Conference was held during May 29, 2020 at London , UK based on the theme “Exploring Advancements in Nursing "

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

Jean Hughes , Dalhousie University , Canada.
Maria-Teresa Parisotto , Fresenius Medical Care, USA.
Kathryn Weaver, University of New Brunswick, Canada.
Geetha Kada , Montgomery College of Nursing, USA.
Dr Geraldine Shaw , Health Service Executive , Ireland.

With the grand success of webinar on nursing skills and techniques, Longdom Conferences is proud to announce the " Global Summit on Personalized Medicine and Health Care" to be held Sep 01-02, 2021 Tokyo, Japan

For More details visit: https://www.longdom.com/personalized-medicine

Abstracts enquiry

Registration enquiry

Contact Enquiry

Phone

WhatsApp

Useful Links

News

Genomics of health

Newsletter